{"id":755886,"date":"2023-05-08T08:15:48","date_gmt":"2023-05-08T12:15:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/"},"modified":"2023-05-08T08:15:48","modified_gmt":"2023-05-08T12:15:48","slug":"agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/","title":{"rendered":"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023"},"content":{"rendered":"<h2>\nLive Conference Call and Webcast at 4:30 p.m. ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">PRINCETON, N.J., May  08, 2023  (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced it will report first quarter 2023 financial results after the market close on\u00a0Thursday, May 11, 2023. Following the release, the Company will host a live conference call and webcast at\u00a04:30 p.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update.<\/p>\n<table style=\"border-collapse: collapse;float:left;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: bottom\">Event<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;vertical-align: bottom\">Agile Therapeutics First Quarter 2023 Financial Results Conference Call<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Date<\/td>\n<td style=\"vertical-align: bottom\">Thursday, May 11, 2023<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Time<\/td>\n<td style=\"vertical-align: bottom\">4:30 p.m. ET \/ 1:30 p.m. PT<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<td style=\"vertical-align: bottom\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"left\">A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U3f1ioPQaN8qw1j1PNuMrvfdZVk7BNx5W9lN36m58pK8kxO4fjrYO4l_8LVgWKocTKqwQqU-D0Da9HbCbqdZ5FGqFil2XgcMRxmPQfDZFPxrhu1pvqEsMm2jjMkXp6v8sG9buGp0qQI_tWMkhRM9-_Kby4n2AJrIf4tyxsT4u8tGH8ETZD6OL1-jIXnz04Ja\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.agiletherapeutics.com\/events-and-presentations<\/a>. To participate in the live conference call via telephone, please register\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0PPY45YOqqorXdhd9rMqontAlmb7_xtD20heJD1V-BCJK-mDA_yQ8KZURtRzlU__o_6V6G8JBQMx8kotObbZBXsJxXhVkCFxYqnGupeBkZEJ5oObb5JnBSXYMFDYATxJVrUoDW_6auMgATFTtJgi5A==\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.<\/p>\n<p align=\"left\">\n        <strong>About<\/strong><br \/>\n        <strong>Agile<\/strong><br \/>\n        <strong>Therapeutics,<\/strong><br \/>\n        <strong>Inc.<\/strong>\n      <\/p>\n<p align=\"left\">Agile Therapeutics is a women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla\u00ae, (levonorgestrel and ethinyl estradiol) transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion\u00ae, which is designed to allow drug delivery through the skin. For more information, please visit the company website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0msOWNvbvvA-5IaoKmd6GHsop5D2lGRB3o94ArN10reH8KdL9v5TJZp2tfZV0COLL8YeKg8pmlmlXfojSKzPXoMw-CHFN727OQB4bvu1TFeID2JnjJYj8vf5yGxZHYwb\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>www.agiletherapeutics.com<\/u><\/strong>. <\/a>The Company may occasionally disseminate material, nonpublic information on the Company\u2019s website, Twitter account (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UCOII6XQsYz0VMX1mBrdm1zLAK_WgX1vOUhfQrVi3N66WCVCSfFt8o0r285ma4yhewFzYIR5ay_8eLNKH6csyg==\" rel=\"nofollow noopener\" target=\"_blank\">@agilether<\/a>), and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_0TsXc2VHWY_cIMf3s2hcn0CaMAiJU6TE--CD1oFHBW4Wui7itPTj6q5eG3HflqH9DfujxtEeoJSvozY8zoDZ1hopqD1pCA3ITD_nBx3hlw5r8Z2UafD29vRyRUQesJd7-NsOji8ktus4fInhuYQmg==\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a> account.<\/p>\n<p align=\"left\">\n        <strong>Contact:<\/strong><br \/>\n        <br \/>Matt Riley<br \/>Head of Investor Relations &amp; Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4gf1OmzMhTqcI0bLz_WAZv0uag0iPYq5pZcTtfuBh6cnZabI-QpoSCNCuEMFYX6jmkMPzNcn2wyavZY9OjbM3Elw4Td6Ib-wkasDRKaGRq4xO5S9T1WBOSI-bCe9DEnK\" rel=\"nofollow noopener\" target=\"_blank\">mriley@agiletherapeutics.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTQzMzJjYTMtNmIwYy00OTk3LWI1NTAtMTU2NTE1MzIzZTgzLTEwMTk0ODk=\/tiny\/Agile-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced it will report first quarter 2023 financial results after the market close on\u00a0Thursday, May 11, 2023. Following the release, the Company will host a live conference call and webcast at\u00a04:30 p.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update. Event Agile Therapeutics First Quarter 2023 Financial Results Conference Call Date Thursday, May 11, 2023 Time 4:30 p.m. ET \/ 1:30 p.m. PT \u00a0 \u00a0 A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. To participate in the live &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-755886","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced it will report first quarter 2023 financial results after the market close on\u00a0Thursday, May 11, 2023. Following the release, the Company will host a live conference call and webcast at\u00a04:30 p.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update. Event Agile Therapeutics First Quarter 2023 Financial Results Conference Call Date Thursday, May 11, 2023 Time 4:30 p.m. ET \/ 1:30 p.m. PT \u00a0 \u00a0 A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. To participate in the live &hellip; Continue reading &quot;Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-08T12:15:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023\",\"datePublished\":\"2023-05-08T12:15:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/\"},\"wordCount\":286,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/\",\"name\":\"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=\",\"datePublished\":\"2023-05-08T12:15:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/","og_locale":"en_US","og_type":"article","og_title":"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 - Market Newsdesk","og_description":"Live Conference Call and Webcast at 4:30 p.m. ET PRINCETON, N.J., May 08, 2023 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women&#8217;s healthcare company, today announced it will report first quarter 2023 financial results after the market close on\u00a0Thursday, May 11, 2023. Following the release, the Company will host a live conference call and webcast at\u00a04:30 p.m. ET\u00a0to discuss the Company\u2019s financial results and provide a business update. Event Agile Therapeutics First Quarter 2023 Financial Results Conference Call Date Thursday, May 11, 2023 Time 4:30 p.m. ET \/ 1:30 p.m. PT \u00a0 \u00a0 A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at\u00a0https:\/\/ir.agiletherapeutics.com\/events-and-presentations. To participate in the live &hellip; Continue reading \"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-08T12:15:48+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023","datePublished":"2023-05-08T12:15:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/"},"wordCount":286,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/","name":"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=","datePublished":"2023-05-08T12:15:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMzE2NSM1NTc4Mjc5IzIwMDc5MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-first-quarter-2023-financial-results-and-provide-business-update-on-thursday-may-11-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agile Therapeutics to Report First Quarter 2023 Financial Results and Provide Business Update on Thursday, May 11, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755886","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=755886"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/755886\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=755886"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=755886"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=755886"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}